Nordic Nanovector: Invitation to Conference Call for Updated Results From the LYMRIT 37-01 Phase 1/2 Trial, to be Presented at ASH

OSLO, Norway, Dec. 8, 2017 /PRNewswire/ — Nordic Nanovector ASA (OSE: NANO) will host a conference call and audio cast on Monday 11 December at 08:00 CET to present the updated results from its ongoing LYMRIT 37-01 Phase 1/2 clinical study of Betalutin® in patients with…